Comparison of Clinical Equivalence of Infliximab and its Biosimilar Combinations with Methotrexate in the Treatment of Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Comparison of Clinical Equivalence of Infliximab and its Biosimilar Combinations with Methotrexate in the Treatment of Rheumatoid Arthritis

Published:2022-03-31 Issue:2 Volume:53 Page:15-24
ISSN:0388-1601
Container-title:Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
language:en
Short-container-title:Jpn. J. Clin. Pharmacol. Ther.

Author:

SHIMIZU Mikiko¹,MIZUTANI Eisuke²,SHIGA Tsuyoshi³,HASHIGUCHI Masayuki³

Affiliation:

1. Department of Pharmaceutics and Pharmacometrics, School of Pharmacy, Shujitsu University, Okayama, Japan

2. Department of Drug Metabolism and Pharmacokinetics, Aomori University Faculty of Pharmaceutical Sciences, Aomori, Japan

3. Department of Clinical Pharmacology and Therapeutics, The Jikei University School of Medicine, Tokyo, Japan

Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Subject

Pharmacology (medical),Pharmacology

Link

https://www.jstage.jst.go.jp/article/jscpt/53/2/53_15/_pdf

Reference20 articles.

1. 1) Yamanaka H, Sugiyama N, Inoue E, Taniguchi A, Momohara S. Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I). Mod Rheumatol. 2014; 24(1）: 33-40. doi: 10.3109/14397595.2013.854059.

2. 2) Smyth CJ. Therapy of rheumatoid arthritis. A pyramidal plan. Postgrad Med. 1972; 51（6）: 31-9. doi: 10.1080/00325481.1972.11698261.

3. 3) Wilske KR, Healey LA. Remodeling the pyramid―a concept whose time has come. J Rheumatol. 1989; 16（5）: 565-7. PMID: 2754660.

4. 4) Pharmaceutical Industry Vision 2021. Toward a Pharmaceutical Industry Policy that Balances Medical Care and Economic Development and Realizes Safe and Secure Lifestyles. Tokyo: Ministry of Health, Labour and Welfare, September 13, 2021.（in Japanese）

5. 5) Pharmaceutical Interview Form, REMICADE^® for I. V. Infusion 100, August 2018, ver. 28.（in Japanese）